Total antibody positive population (No.) | Underlying disease or not (No.) | IgA + (%) | IgM + (%) | IgG + (%) | Nabs + (%) |
---|---|---|---|---|---|
Baseline (313) | No (216) | 43 (19.91%) | 26 (12.04%) | 216 (100.00%) | 92 (42.59%) |
Yes (97) | 22 (22.68%) | 7 (7.22%) | 97 (100.00%) | 43 (44.33%) | |
First follow-up (212) | No (146) | 16 (10.96%) | 4 (2.74%) | 145 (99.32%) | 67 (45.89%) |
Yes (66) | 11 (16.67%) | 1 (1.52%) | 66 (100.00%) | 35 (53.03%) | |
Second follow-up (238) | No (170) | 11 (6.47%) | 3 (1.76%) | 168 (98.82%) | 88 (51.76%) |
Yes (68) | 6 (8.82%) | 1 (1.47%) | 63 (92.65%) | 36 (52.94%) |